Skip to content

SIGA Technologies Inc SIGA Stock Analysis

  • Nasdaq
  • Stock
  • Market closed · opens Monday 9:30 AM ET

$3.10 up $0.13, 4.38% at close Nov 6

Last close · Previous close $2.97

Market cap
$222.34MAt the Nov 6 close
P/E ratio
n/mLoss over last 12 months
Diluted EPS
−$0.05Last 12 months
Dividend yield
19.35%Last 12 months

Price chart

$3.10up $0.13, 4.38%Fri, Nov 6 session

Use the left and right arrow keys to move along the chart.

Chart period
IEX trades, regular session · Times in ET
Price data

Trading

At last close

  • Previous close$2.97Nov 5
  • Volume330.84KNov 6 session
  • Avg. volume463.36KLast 21 sessions
  • 52-week range: $2.83 to $7.11; now $3.10
Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

Performance

Past performance, measured to the Nov 6 close. Total return includes reinvested dividends. Compared with the S&P 500, using SPY.

Return type

SIGA beat the S&P 500 in 1 of 7 periods.

SIGA total returns compared with the S&P 500
PeriodSIGA and S&P 500vs S&P 500
Short term
1M
SIGA: down 5.8%
S&P 500: down 5.6%
SIGA trailed the S&P 500 by 0.2 percentage points
3M
SIGA: down 0.6%
S&P 500: down 4.1%
SIGA beat the S&P 500 by 3.5 percentage points
YTD
SIGA: down 42.5%
S&P 500: up 8.7%
SIGA trailed the S&P 500 by 51.2 percentage points
1Y
SIGA: down 57.0%
S&P 500: up 10.9%
SIGA trailed the S&P 500 by 67.9 percentage points
Long term
3Y
SIGA: down 17.6%
S&P 500: up 75.0%
−6.2% vs +20.5% a year
SIGA trailed the S&P 500 by 92.6 percentage points
5Y
SIGA: down 35.7%
S&P 500: up 67.8%
−8.5% vs +10.9% a year
SIGA trailed the S&P 500 by 103.5 percentage points
10Y
SIGA: up 144.9%
S&P 500: up 313.1%
+9.4% vs +15.2% a year
SIGA trailed the S&P 500 by 168.2 percentage points

$10,000 invested in SIGA 10 years ago (Nov 4, 2016) would be worth about $24,489 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.

All-time high

$26.15

Closing high on . Now 88.1% below that record.

Split-adjusted daily closes since Sep 10, 1997.

Stock splits

SIGA hasn’t split since its price history begins in 1997.

Valuation

The Nov 6 close compared with the last 12 months of reported results (the four quarters to Jun 30, 2026). Tap a metric to see how it’s calculated.

Price-to-earnings (P/E)

n/mDiluted EPS of −$0.05 over the last 12 months

A P/E ratio isn’t meaningful while earnings over the last 12 months are negative. When SIGA was profitable over the past five years, its P/E ranged from 4.7× to 42.4×, with a median of 8.0×. How to read P/E

Other valuation measures

  • 4.1×Last 12 months’ revenue
  • 1.3×Book value as of Jun 30, 2026
  • −9.22%Last 12 months’ free cash flow
  • $104.76MAt the Nov 6 close

Build your own SIGA DCF in Excel. Value SIGA Technologies with your own growth and margin assumptions.Browse DCF models Free DCF calculator

Financials

Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.

Chart periods

Revenue and net income

Last 12 months, with the change from the 12 months before

Revenue
$53.66Mdown 70.1%
Net income
−$2.79M
Diluted EPS
−$0.05
Last 8 fiscal quarters
Data table
SIGA quarterly results
PeriodRevenueNet incomeDiluted EPS
Q3 FY24 (Sep 30, 2024)$10.01M$1.34M$0.02
Q4 FY24 (Dec 31, 2024)$81.47M$45.76M$0.63
Q1 FY25 (Mar 31, 2025)$7.04M−$408.22K−$0.01
Q2 FY25 (Jun 30, 2025)$81.12M$35.48M$0.49
Q3 FY25 (Sep 30, 2025)$2.62M−$6.37M−$0.09
Q4 FY25 (Dec 31, 2025)$3.79M−$5.43M−$0.08
Q1 FY26 (Mar 31, 2026)$6.24M−$3.45M−$0.05
Q2 FY26 (Jun 30, 2026)$41.00M$12.46M$0.17

Margins

  • Gross 54.4%
  • Operating −20.8%
  • Net −5.2%

The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you

Cash flow

  • −$20.50MLast 12 months
  • Operating cash flow−$20.17MLast 12 months
  • Capital spending$330.12KLast 12 months
  • −38.2%Last 12 months

Shareholder returns

  • $0.00Last 12 months
  • Dividends paid$43.56MLast 12 months
  • Total returned$43.56MLast 12 months

Balance sheet

  • $117.58MAs of Jun 30, 2026
  • Total debt$0.00As of Jun 30, 2026
  • Net cash$117.58MAs of Jun 30, 2026
  • 21.72As of Jun 30, 2026
  • 0.00As of Jun 30, 2026

Financial strength

  • 2 of 9Last 12 months
    vs the 12 before
  • −1.5%Last 12 months
  • −1.3%Last 12 months

Dividends

Cash dividends per share by ex-dividend year, adjusted for splits.

Dividends per share

By ex-dividend date, split-adjusted
Data table
SIGA dividends per share by year
YearPer share
2016$0.000
2017$0.000
2018$0.000
2019$0.000
2020$0.000
2021$0.000
2022$0.45
2023$0.45
2024$0.60
2025$0.60
2026 (to date)$0.60

Dividend details

  • $0.60Per share, last 12 months
  • 19.35%; 5-yr low 1.72%, 5-yr high 27.52%Last 12 months
  • $0.60Ex-dividend
  • FrequencyAnnual1 payment in the last 12 months

About SIGA Technologies Inc

® SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Our lead product is TPOXX ®, also known as tecovirimat and ST-246 ®, an orally administered and IV formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the US maintains a supply of TPOXX under Project BioShield. The oral formulation of TPOXX was approved by the FDA for the treatment of smallpox in 2018, and the IV formulation was approved for the same indication in 2022. The full label is available by clicking here. Oral tecovirimat received approval from the European Medicines Agency (EMA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom in 2022. The EMA and UK approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. The full label is available by clicking here. In September 2018, SIGA signed a contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, for additional procurement and development related to both oral and intravenous formulations of TPOXX.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
New York, USA
Exchange
Nasdaq
Asset type
Common stock
Price history since

SIGA news

SIGA stock FAQ

What is SIGA stock’s price today?

SIGA Technologies (SIGA) traded at $3.10 at the close on , up $0.13 (4.38%) from the previous close of $2.97. Over the past 52 weeks it has traded between $2.83 and $7.11.

If you invested $1,000 in SIGA 10 years ago, how much would you have now?

With dividends reinvested, $1,000 invested in SIGA on would be worth about $2,449 at the close on , a total return of +144.9%. The same $1,000 would be worth $643 if invested five years ago, $430 if invested one year ago, and $1,418 if invested 20 years ago. Past performance doesn’t predict future returns.

What is SIGA Technologies’s market cap?

SIGA Technologies’s market capitalization is about $222.3 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $3.10 (how market cap works). SIGA Technologies reported 71.72M shares outstanding at the end of its latest quarter ().

What is SIGA’s P/E ratio?

SIGA’s P/E ratio isn’t meaningful right now because its earnings over the four quarters to are negative (diluted EPS of −$0.05). When it was profitable over the past five years, its P/E ranged from 4.7 to 42.4.

How much revenue does SIGA Technologies make?

SIGA Technologies reported $53.7 million of revenue over the four quarters to , down 70.1% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $41.0 million, down 49.5% from a year earlier.

Is SIGA Technologies profitable?

Not over the four quarters to . SIGA Technologies reported a net loss of $2.8 million across those four quarters on $53.7 million of revenue.

What are SIGA’s earnings per share?

SIGA’s diluted earnings per share were −$0.05 over the four quarters to , compared with $1.13 in the twelve months before. The latest quarter (Q2 FY26) brought $0.17 per share, against $0.49 a year earlier (how EPS works).

Does SIGA pay a dividend?

Yes. SIGA Technologies pays a annual dividend. The most recent was $0.60 per share, with an ex-dividend date of . Over the last twelve months it paid $0.60 per share, a 19.35% yield at the close (how dividend yield works).

Based on the last 12 months’ payments ($0.60 per share), and if the next 12 months match the last 12, 100 shares would receive about $60 over 12 months, and $1,000 over 12 months would take about 1,667 shares, roughly $5,168 at the close. Dividends can change.

What is SIGA’s 52-week high and low?

Over the past 52 weeks SIGA has traded as low as $2.83 and as high as $7.11. At $3.10 at the close on , it is 56.4% below that high and 9.5% above the low.

What is SIGA’s all-time high?

SIGA’s highest closing price was $26.15 on , adjusted for stock splits. At $3.10 at the close on , it is 88.1% below that record.

Has SIGA stock ever split?

No. SIGA hasn’t split since its price history begins in 1997.

How has SIGA stock performed?

Including dividends and measured to the close on , SIGA has returned −42.5% so far this year and −57.0% over the past year, and −35.7% over five years (−8.5% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.

What sector and industry is SIGA Technologies in?

SIGA Technologies is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry, and is headquartered in New York, USA.

What exchange does SIGA trade on?

SIGA Technologies trades on the Nasdaq under the ticker symbol SIGA. Its price history on this dashboard begins on .

Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.

This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).

The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.

Contact Ryan

Get in touch

Contact Me

Have a question or want to work together? Fill out the form below and we'll get back to you as soon as possible.

Contact Form Demo

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.